SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for SOLIGENIX, INC. (SNGX) (CIK 0000812796) (SNGX) — Jun 19, 2013

SOLIGENIX, INC. (SNGX) (CIK 0000812796)
Date: June 19, 2013 · CIK: 0000812796 · Accession: 0000000000-13-033415

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-184762

Date
June 19, 2013
Author
/s/ Daniel Greenspan for
Form
UPLOAD
Company
SOLIGENIX, INC. (SNGX) (CIK 0000812796)

Letter

June 19, 2013 Via E -Mail Dr. Christopher J. Schaber, Ph.D. President and Chief Executive Officer Soligenix, Inc. 29 Emmons Drive, Suite C -10 Princeton, NJ 08540

Re: Soligenix, Inc. Registration Statement on Form S-1 Filed June 13, 2013 File No. 333-184762

Dear Dr. Schaber :

We have reviewed your amended registration statement and have the following comment. We have limited our review of your registration statement to those issues we have addressed in our comments.

Please respond to this letter by amending your registration statement as requested. Where you do not believe our comments apply to your facts and circu mstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments.

Exhibit 5.1

Please file a revised legal opinion that opines that:

 the Units themselves are binding obligations of the registrant in accordance with Section II.B.1.h of Staff Legal Bulletin No. 19;

 each Warrant included in the Units is a binding obligation of the registrant in accordance with Section II.B.1.f of Staff Legal Bulletin No. 19; and

 each preferred stock purchase right attached to Soligenix’s common stock is a binding obligation of the registrant in accordance with Section II.B.1.g of Staff Legal Bulletin No. 19.

In addition, please delete your assumption that the registrant has an adequate number of authorized shares of common stock in accordance with II.B.3.a of Staff Legal Bulletin No. 19.

Dr. Christopher J. Schaber, Ph.D. Soligenix, Inc. June 19, 2013 Page 2

We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 1933 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.

Notwithstanding our comments , in the event you request acceleration of the effective date of the pending registration statement please provide a written statement from the company acknowledging that:

 should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 the action of the Commission or the staff, acting pursuant t o delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 the company may not assert staff comments and the declaration of effect iveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please refer to Rules 460 and 461 regarding requests for acceleration. We will consider a written request for acceler ation of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the securities specified in the above registration statement. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.

Please contact Amy Reisch auer at (202) 551 -3793, Daniel Greenspan at (202) 551 -3623 , or me at (202) 551 -3715 with any other questions.

Sincerely,
/s/ Daniel Greenspan for

Show Raw Text
June 19, 2013

Via E -Mail
Dr. Christopher J. Schaber, Ph.D.
President and Chief Executive Officer
Soligenix, Inc.
29 Emmons Drive, Suite C -10
Princeton, NJ 08540

Re: Soligenix, Inc.
  Registration Statement on Form S-1
Filed  June 13, 2013
  File No.  333-184762

Dear Dr. Schaber :

We have reviewed your amended registration statement and have the following comment.
We have limited our review of your registration statement to those issues we have addressed in
our comments.

Please respond to this letter by amending your registration statement as requested.   Where
you do not believe our comments apply to your facts and circu mstances or do not believe an
amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.

Exhibit 5.1

Please file a revised legal opinion that opines that:

 the Units themselves are binding obligations of the registrant in accordance with
Section II.B.1.h of Staff Legal Bulletin No. 19;

 each Warrant included in the Units is a binding obligation  of the registrant in
accordance with Section II.B.1.f of Staff Legal Bulletin No. 19; and

 each preferred stock purchase right attached to Soligenix’s common stock is a binding
obligation of the registrant in accordance with Section II.B.1.g of Staff Legal  Bulletin
No. 19.

In addition, please delete your assumption that the registrant has an adequate number of
authorized shares of common stock in accordance with II.B.3.a of Staff Legal Bulletin No. 19.

Dr. Christopher J. Schaber, Ph.D.
Soligenix, Inc.
June 19, 2013
Page 2

 We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 1933 and
all applicable Securities Act rules require.   Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.

Notwithstanding our comments , in the event you request acceleration of the effective date
of the pending registration statement please provide a written statement from the company
acknowledging that:

 should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;

 the action of the Commission or the staff, acting pursuant t o delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

 the company may not assert staff comments and the declaration of effect iveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

Please refer to Rules 460 and 461 regarding requests for acceleration.  We will consider a
written request for acceler ation of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibilities under
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed
public offering of the securities specified in the above registration statement.  Please allow
adequate time for us to review any amendment prior to the requested effective date of the
registration statement.

Please contact Amy Reisch auer at (202) 551 -3793, Daniel Greenspan  at (202) 551 -3623 ,
or me at (202) 551 -3715 with any other questions.

Sincerely,

 /s/ Daniel Greenspan for

Jeffrey P. Riedler
Assistant Director
cc: Via E -Mail
Leslie J. Croland
Duane Morris LLP
200 South Biscayne Boulevard, Suite 3400
Miami, FL 33131 -2318